Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Novel equine ECG technique gives hope for better stroke prevention in humans
Owing to its intermittent nature, PAF in horses is difficult to diagnose.
Method allows for the rapid detection of atrial fibrillation in horses. 

Researchers at the University of Surrey have discovered a new electrocardiogram (ECG) technique that can quickly detect a difficult-to-diagnose-condition in horses, that is also a major cause of stroke in humans.

Writing in the journal Nature Scientific Reports, researchers describe the technique, which can rapidly diagnose paroxysmal atrial fibrillation (PAF), a condition that causes rapid, erratic heartbeats.

Owing to the intermittent nature of the condition, PAF is tricky to diagnose and can impact a race horse's performance. In some cases, the condition can be fatal.

In humans, this abnormal heart rhythm can disrupt the blood flow in the upper two chambers of the heart, leading to the formation of blood clots. Such clots may then block blood vessels elsewhere in the body, including the brain, resulting in cognitive decline and stroke.

In the study, Dr Kamalan Jeevaratnam and his team obtain EGG recordings from healthy horses and those diagnosed with PAF. ECG traces with no other electrical disturbances were converted to a string of computational numbers using a range of detection algorithms.

The researchers found that ECG results recorded at rest, and processed by the novel detection method, were significantly different between horses with and without PAF. This allowed for the identification of horses with PAF from sinus-rhythm ECGs with high accuracy.

Scientists say that it is vital that PAF is identified in good time for treatment to be effective. Normal heart rhythm could be restored by electrical stimulation or antiarrhythmic drugs. Anti-coagulation drugs might prevent the formation of blood clots preventing strokes or greatly reduce their consequences.

“I am very happy to see that in horses we obtained such excellent results and came up with a tool which could be easily used even by a non-professional,” commented lead author of the study, Dr Vadim Alexeeno. “It was also very exciting to devise the new approach of ECG parsing, which is absolutely essential for high sensitivity and specificity of our method”.

Dr Jeevaratnam added: “The fascinating aspect of this study is that we are looking at the arrhythmia which typically is provoked by high heart rate, but we diagnose it looking at low heart rate recordings.

“There is no need to exercise the horse and the analysis could be done in minutes, using low power computers. As a clinician, I think such analysis will greatly facilitate detection of this arrhythmia and it will promote the use of ECG by my colleagues.”

Dr Jeevaratnam is in discussion with several other UK and US groups to further this research into human studies, while at the same time exploring the notion of partnering with device companies in the equine industry.


Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.